Proteasome Inhibitors Block Development ofPlasmodium Spp.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.42.10.2731
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Proteasome Inhibitors Block Ikaros Degradation by Lenalidomide in Multiple Myeloma

Haematologica
Hematology
2015English

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Proteasome Inhibitors in Cancer Therapy

2004English

Synthesis and Activity of Proteasome Inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2013English

Trypanosoma Brucei: Β2-Selective Proteasome Inhibitors Do Not Block the Proteasomal Trypsin-Like Activity but Are Trypanocidal

Molecular and Biochemical Parasitology
ParasitologyMolecular Biology
2019English

Advances in and Applications of Proteasome Inhibitors

Current Opinion in Chemical Biology
BiochemistryAnalytical Chemistry
2008English

Inhibition of Proteasome Deubiquitinase Activity: A Strategy to Overcome Resistance to Conventional Proteasome Inhibitors?

Drug Resistance Updates
Cancer ResearchOncologyInfectious DiseasesPharmacology
2015English

New Betulinic Acid Derivatives as Potent Proteasome Inhibitors

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2011English

Ixazomib Cardiotoxicity: A Possible Class Effect of Proteasome Inhibitors

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy